1. Nā ʻano: ʻulaʻula ʻeleʻele akaka.
2. Puuwai Puʻuwai.
3. Ke Kaʻina Hana: Hoʻopuka ʻia ka Cytochrome C Solution mai ka puʻuwai puaʻa olakino.
4. Nā hōʻailona a me ka hoʻohana ʻana: Hoʻohana ʻia ʻo Cytochrome C Solution ma ke ʻano he adjuvant first-aid therapy no nā histanoxia like ʻole, e like me ka make carbon monoxide, hypnotic drug poisoning, cyanide poisoning, neonatal suffocation, serious shock phase anaerobic, cerebrovascular accident, concussion sequela, dyspnea kumu. ʻO kahi ʻāpana o ke kaulahao lawe electron i ka mitochondria, cytochrome c ua manaʻo ʻia ʻo ia ka paʻakikī hana i hoʻohana ʻia i ka haʻahaʻa haʻahaʻa laser therapy (LLLT), e hoʻonui ai i ka hana metabolic a hoʻokuʻu i ka ikehu hou aʻe no ka hoʻoponopono ʻana i ka ʻiʻo. Hōʻike ia i ka hana peroxidase ma o ka oxidation o nā mea hāʻawi electron like ʻole e like me 2,2-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), 2-keto-4 - thiomethyl butyric acid a me 4-aminoantipyrine.Hoʻohana ʻia ia ma ke ʻano he mea uʻi nui i nā ala apoptotic.
· Ua hala i ka GMP Kina
· 27 makahiki o ka moʻolelo R&D biological enzyme
· Hiki ke ʻimi ʻia nā mea maka
· E hoʻokō me ka CP a me ka mea kūʻai maʻamau
· Hoʻokuʻu aku i nā ʻāina he 30 a me nā ʻāina
· Loaʻa ka mana o ka hoʻokele ʻōnaehana maikaʻi e like me US FDA, Japan PMDA, South Korea MFDS, etc.
Nā mea ho'āʻo | CP | |
Nā huaʻōlelo | ʻulaʻula ʻulaʻula ʻulaʻula hoʻonā | |
ʻIkepili | Kūlike | |
Nā hoʻāʻo | Hao | 0.40%~0.46% |
Endotoxin bacteria | < 5.0EU/mg | |
Hoʻāʻo allergy | Kūlike | |
Ka hana | ≥ 95% | |
ʻIke | ≥ 15mg/ml | |
ʻO nā mea ʻeleʻele microbial | TAMC | ≤ 100cfu/g |
TYMC | ≤ 100cfu/g | |
E.coli | Kūlike | |
Salmonella | Kūlike |